148 related articles for article (PubMed ID: 37873213)
1. Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases.
Collins JC; Magaziner SJ; English M; Hassan B; Chen X; Balanda N; Anderson M; Lam A; Fernandez-Pol S; Kwong B; Greenberg PL; Terrier B; Likhite ME; Kosmider O; Wang Y; Samara NL; Walters KJ; Beck DB; Werner A
bioRxiv; 2023 Oct; ():. PubMed ID: 37873213
[TBL] [Abstract][Full Text] [Related]
2. Shared and distinct mechanisms of UBA1 inactivation across different diseases.
Collins JC; Magaziner SJ; English M; Hassan B; Chen X; Balanda N; Anderson M; Lam A; Fernandez-Pol S; Kwong B; Greenberg PL; Terrier B; Likhite ME; Kosmider O; Wang Y; Samara NL; Walters KJ; Beck DB; Werner A
EMBO J; 2024 May; 43(10):1919-1946. PubMed ID: 38360993
[TBL] [Abstract][Full Text] [Related]
3. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Ferrada MA; Savic S; Cardona DO; Collins JC; Alessi H; Gutierrez-Rodrigues F; Kumar DBU; Wilson L; Goodspeed W; Topilow JS; Paik JJ; Poulter JA; Kermani TA; Koster MJ; Warrington KJ; Cargo C; Tattersall RS; Duncan CJA; Cantor A; Hoffmann P; Payne EM; Bonnekoh H; Krause K; Cowen EW; Calvo KR; Patel BA; Ombrello AK; Kastner DL; Young NS; Werner A; Grayson PC; Beck DB
Blood; 2022 Sep; 140(13):1496-1506. PubMed ID: 35793467
[TBL] [Abstract][Full Text] [Related]
4. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
5. Somatic Mutations in
Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
[TBL] [Abstract][Full Text] [Related]
6. VEXAS syndrome.
Nakajima H; Kunimoto H
Int J Hematol; 2024 May; ():. PubMed ID: 38819628
[TBL] [Abstract][Full Text] [Related]
7. Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome.
Ospina Cardona D; Rodriguez-Pinto I; Iosim S; Bonet N; Mensa-Vilaro A; Wong MK; Ho G; Tormo M; Yagüe J; Shon W; Wallace D; Casals F; Beck DB; Abuav R; Arostegui JI
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38552317
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing can misread high variant allele fraction of somatic variants in UBA1 as hemizygous in VEXAS syndrome: a case report.
Wilke MVMB; Morava-Kozicz E; Koster MJ; Schmitz CT; Foster SK; Patnaik M; Warrington KJ; Klee EW; Pinto E Vairo F
BMC Rheumatol; 2022 Aug; 6(1):54. PubMed ID: 36038944
[TBL] [Abstract][Full Text] [Related]
9. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
10. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
[TBL] [Abstract][Full Text] [Related]
11. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N; Dulau-Florea A; Calvo KR
Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
[TBL] [Abstract][Full Text] [Related]
12. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A
Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307
[TBL] [Abstract][Full Text] [Related]
13. VEXAS Syndrome-Review.
Zhang Y; Dong X; Wang H
Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome.
Chiaramida A; Obwar SG; Nordstrom AEH; Ericsson M; Saldanha A; Ivanova EV; Griffin GK; Khan DH; Belizaire R
Blood Adv; 2023 Dec; 7(24):7445-7456. PubMed ID: 38091008
[TBL] [Abstract][Full Text] [Related]
15. Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
Kirino Y
Intern Med; 2024 Feb; ():. PubMed ID: 38296470
[TBL] [Abstract][Full Text] [Related]
16. An update on VEXAS syndrome.
Al-Hakim A; Savic S
Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
[TBL] [Abstract][Full Text] [Related]
17. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.
Wu Z; Gao S; Gao Q; Patel BA; Groarke EM; Feng X; Manley AL; Li H; Ospina Cardona D; Kajigaya S; Alemu L; Quinones Raffo D; Ombrello AK; Ferrada MA; Grayson PC; Calvo KR; Kastner DL; Beck DB; Young NS
Cell Rep Med; 2023 Aug; 4(8):101160. PubMed ID: 37586319
[TBL] [Abstract][Full Text] [Related]
18. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
Shaukat F; Hart M; Burns T; Bansal P
Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
[TBL] [Abstract][Full Text] [Related]
19. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Obiorah IE; Patel BA; Groarke EM; Wang W; Trick M; Ombrello AK; Ferrada MA; Wu Z; Gutierrez-Rodrigues F; Lotter J; Wilson L; Hoffmann P; Cardona DO; Patel N; Dulau-Florea A; Kastner DL; Grayson PC; Beck DB; Young NS; Calvo KR
Blood Adv; 2021 Aug; 5(16):3203-3215. PubMed ID: 34427584
[TBL] [Abstract][Full Text] [Related]
20. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
Stiburkova B; Pavelcova K; Belickova M; Magaziner SJ; Collins JC; Werner A; Beck DB; Balajkova V; Salek C; Vostry M; Mann H; Vencovsky J
Arthritis Rheumatol; 2023 Jul; 75(7):1285-1290. PubMed ID: 36762418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
